menu toggle
Thursday, November 26 - Friday, November 27
Cencora will be closed on Thursday, November 26 in observance of the Thanksgiving holiday. There will be no deliveries on this day and our Customer Service and Customer Systems Support teams will be unavailable. Our offices will also be closed on Friday, November 27. While deliveries for non-refrigerated product will be attempted on Friday, our offices will be closed. Customer Service may be limited and Customer System Support will also be limited and available by email only. Please review our full holiday schedule for more detailed information and to plan your orders accordingly.

June 19, 2023

Now available EPKINLY™

EPKINLY™ (epcoritamab-bysp) injection, for subcutaneous use, is a bispecific CD20-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B-cell lymphoma after two or more lines of systemic therapy. 


This indication is approved under accelerated approval based on response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Please see full prescribing information here.

We are NABP accredited